Sotera Health Company (NASDAQ:SHC) Stock Has Consensus Price Target of $21.50

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $21.50.

Several equities analysts have issued reports on SHC shares. Barclays lifted their price objective on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. UBS Group set a $19.00 target price on Sotera Health in a research note on Wednesday, June 24th. Weiss Ratings raised Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Finally, Citigroup increased their price objective on shares of Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 7th.

Insider Activity

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 1,294,515 shares of company stock worth $23,999,528. 15.36% of the stock is owned by company insiders.

Institutional Investors Weigh In On Sotera Health

Institutional investors have recently added to or reduced their stakes in the stock. ABS Direct Equity Fund LLC boosted its position in Sotera Health by 150.0% during the 2nd quarter. ABS Direct Equity Fund LLC now owns 125,000 shares of the company’s stock worth $2,219,000 after acquiring an additional 75,000 shares during the last quarter. Darsana Capital Partners LP grew its stake in Sotera Health by 3.8% in the second quarter. Darsana Capital Partners LP now owns 27,000,000 shares of the company’s stock valued at $479,250,000 after purchasing an additional 1,000,000 shares in the last quarter. Integrated Wealth Concepts LLC grew its stake in Sotera Health by 3.0% in the second quarter. Integrated Wealth Concepts LLC now owns 19,443 shares of the company’s stock valued at $345,000 after purchasing an additional 559 shares in the last quarter. IFP Advisors Inc increased its position in shares of Sotera Health by 150.8% during the 2nd quarter. IFP Advisors Inc now owns 3,509 shares of the company’s stock worth $62,000 after purchasing an additional 2,110 shares during the last quarter. Finally, Allworth Financial LP raised its stake in shares of Sotera Health by 95.8% during the 2nd quarter. Allworth Financial LP now owns 14,755 shares of the company’s stock worth $262,000 after purchasing an additional 7,218 shares in the last quarter. 91.03% of the stock is owned by institutional investors.

Sotera Health Trading Up 0.9%

Shares of Sotera Health stock opened at $18.45 on Friday. The stock has a market capitalization of $5.27 billion, a P/E ratio of 32.37 and a beta of 1.77. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The company has a 50-day simple moving average of $18.55 and a 200 day simple moving average of $16.69. Sotera Health has a 12-month low of $13.09 and a 12-month high of $19.85.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The business had revenue of $321.38 million for the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.Sotera Health’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Research analysts expect that Sotera Health will post 0.86 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Company (NASDAQ: SHC) is a global provider of sterilization, laboratory testing and other healthcare services designed to support infection prevention and product safety. The company serves medical device, pharmaceutical and healthcare customers, helping them meet regulatory and quality requirements throughout the product life cycle.

Sotera Health operates through three primary businesses. Sterigenics provides contract sterilization and microbial reduction services for medical devices, pharmaceutical products, food and other products.